These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31711105)

  • 1. The Colorado Cognitive Assessment (CoCA): Development of an Advanced Neuropsychological Screening Tool.
    Gurnani AS; Lin SS; Gavett BE
    Arch Clin Neuropsychol; 2020 Feb; 35(2):176-187. PubMed ID: 31711105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
    Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
    Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF).
    Springer A; Monsch AU; Dutilh G; Coslovsky M; Kievit RA; Bonati LH; Conen D; Aeschbacher S; Beer JH; Schwenkglenks M; Fischer U; Meyer-Zuern CS; Conte G; Moutzouri E; Moschovitis G; Kühne M; Osswald S;
    PLoS One; 2020; 15(10):e0240167. PubMed ID: 33035257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normative Data for the Montreal Cognitive Assessment in a Lebanese Older Adult Population.
    Hayek M; Tarabey L; Abou-Mrad T; Fadel P; Abou-Mrad F
    J Clin Neurosci; 2020 Apr; 74():81-86. PubMed ID: 32007375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: A validation study.
    Konstantopoulos K; Vogazianos P
    Appl Neuropsychol Adult; 2021; 28(1):48-52. PubMed ID: 30939943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis.
    Tsai CF; Lee WJ; Wang SJ; Shia BC; Nasreddine Z; Fuh JL
    Int Psychogeriatr; 2012 Apr; 24(4):651-8. PubMed ID: 22152127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment.
    Chen KL; Xu Y; Chu AQ; Ding D; Liang XN; Nasreddine ZS; Dong Q; Hong Z; Zhao QH; Guo QH
    J Am Geriatr Soc; 2016 Dec; 64(12):e285-e290. PubMed ID: 27996103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor structure of the Montreal Cognitive Assessment in Parkinson disease.
    Smith CR; Cavanagh J; Sheridan M; Grosset KA; Cullen B; Grosset DG
    Int J Geriatr Psychiatry; 2020 Feb; 35(2):188-194. PubMed ID: 31736141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation and validation into Portuguese language of the six-item cognitive impairment test (6CIT).
    Apóstolo JLA; Paiva DDS; Silva RCGD; Santos EJFD; Schultz TJ
    Aging Ment Health; 2018 Sep; 22(9):1184-1189. PubMed ID: 28741373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal Assessment Battery in Early Cognitive Impairment: Psychometric Property and Factor Structure.
    Goh WY; Chan D; Ali NB; Chew AP; Chuo A; Chan M; Lim WS
    J Nutr Health Aging; 2019; 23(10):966-972. PubMed ID: 31781726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usability and Validity of a Battery of Computerised Cognitive Screening Tests for Detecting Cognitive Impairment.
    Scanlon L; O'Shea E; O'Caoimh R; Timmons S
    Gerontology; 2016; 62(2):247-52. PubMed ID: 26113397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative capacity and construct validity of the Clock Drawing Test in Mild Cognitive Impairment and Alzheimer's disease.
    Duro D; Freitas S; Tábuas-Pereira M; Santiago B; Botelho MA; Santana I
    Clin Neuropsychol; 2019 Oct; 33(7):1159-1174. PubMed ID: 30422076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.